Neo-Tran en es it fr

Neo-Tran Brand names, Neo-Tran Analogs

Neo-Tran Brand Names Mixture

  • No information avaliable

Neo-Tran Chemical_Formula


Neo-Tran RX_link

No information avaliable

Neo-Tran fda sheet

Neo-Tran msds (material safety sheet)

Neo-Tran Synthesis Reference

No information avaliable

Neo-Tran Molecular Weight

309.469 g/mol

Neo-Tran Melting Point

< 25 oC

Neo-Tran H2O Solubility

Soluble as HCl salt

Neo-Tran State


Neo-Tran LogP


Neo-Tran Dosage Forms

Tablets (oral, 1 mg)

Neo-Tran Indication

Used for the symptomatic treatment of parkinsonism.

Neo-Tran Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Neo-Tran Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Neo-Tran side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Neo-Tran Patient Information

Neo-Tran Organisms Affected

Humans and other mammals